Utah legislation · 2026 General Session
Utah SCR5: Concurrent Resolution Directing PEHP Regarding Pain Medication
Status: Signed into law, March 24, 2026
This resolution relates to non-opioid pain medication and state employee health coverage.
What the bill says
From the enrolled text, March 5, 2026:
0 Concurrent Resolution Directing PEHP Regarding Pain Medication 2026 GENERAL SESSION STATE OF UTAH Chief Sponsor: Todd Weiler House Sponsor: Raymond P. Ward LONG TITLE General Description: This resolution relates to non-opioid pain medication and state employee health coverage. Highlighted Provisions: This resolution: - directs the Public Employees' Benefit and Insurance Program to adjust the state employee health insurance plan related to non-opioid pain medication. Money Appropriated in this Bill: None Other Special Clauses: None Be it resolved by the Legislature of the state of Utah, the Governor concurring therein: WHEREAS, in accordance with Section 49-20-201 , the state participates in the Public Employees' Benefit and Insurance Program (PEHP); WHEREAS, Utah has experienced significant harm from the opioid epidemic, with thousands of Utahns suffering from opioid addiction and hundreds dying from opioid-related overdoses annually; WHEREAS, the federal Centers for Disease Control and Prevention has issued guidelines recommending that non-opioid therapies be considered as first-line treatments for chronic pain; WHEREAS, many health insurance plans impose utilization barriers to accessing non-opioid pain medications through: 1. higher copayments and coinsurance rates compared to opioid medications; 2. prior authorization requirements that delay or prevent access to non-opioid alternatives; 3. quantity limits that restrict the supply of non-opioid medications; and 4. formulary placement that designates non-opioid options as non-preferred or specialty drugs; WHEREAS, some health …
Sponsors
- Todd Weiler (R, 8) · primary sponsor
- Ward, Raymond P. (R, 19)
Latest actions
- : Governor Signed
- : Senate/ to Governor
- : Senate/ received enrolled bill from Printing
- : Senate/ enrolled bill to Printing
- : Enrolled Bill Returned to House or Senate
- : Draft of Enrolled Bill Prepared
- : Bill Received from Senate for Enrolling
- : Senate/ signed by President/ sent for enrolling
- : Senate/ received from House
- : House/ to Senate
Votes
- House/ passed 3rd reading (March 4, 2026): 72 yea, 0 nay, passed
- House Comm - Favorable Recommendation (February 27, 2026): 12 yea, 0 nay, passed
- Senate/ passed 3rd reading (February 23, 2026): 26 yea, 0 nay, passed
- Senate/ passed 2nd reading (February 20, 2026): 23 yea, 0 nay, passed
- Senate Comm - Favorable Recommendation (February 3, 2026): 6 yea, 0 nay, passed
- Senate Comm - Amendment Recommendation (February 3, 2026): 3 yea, 0 nay, passed
Subjects: Health Care, Health Insurance, Health and Human Services, Public Employees' Health Program, Public Retirement and Insurance, Controlled Substances, Public Employees Insurance and Benefits, Opioids
Common questions
- What is SCR5?
- SCR5 is a bill in the Utah Legislature (2026 General Session): Concurrent Resolution Directing PEHP Regarding Pain Medication.
- What does SCR5 do?
- This resolution relates to non-opioid pain medication and state employee health coverage.
- What is the status of SCR5?
- Signed into law as of March 24, 2026. Latest action: Governor Signed (March 24, 2026).
- Who sponsored SCR5?
- Todd Weiler (R, 8), with 1 co-sponsor.
- Where is the official record for SCR5?
- On the Utah Legislature website: https://le.utah.gov/~2026/bills/static/SCR005.html
Source: official Utah record. Tracked by Delilah, AI for legislation across all 50 states and Congress.